Parkinson's disease

doctor examining brain mri scans

Gain's phase 1 win paves way to prove Parkinson's drug's worth

Gain aims to prove the efficacy of its Parkinson’s therapy next year after the brain-penetrant molecule demonstrated “peripheral target engagement.”

James Waldron Aug 29, 2024 10:05am

microscope

Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B

Aug 21, 2024 11:00am

MA strategy deal block push come together form

In struggling Hepion, Israeli biotech spies path to go public

Jul 22, 2024 9:14am

Parkinsons

Pharma giants to take part in Parkinson’s biomarker project

Jul 17, 2024 4:18pm

success failure signposts

Annovis glosses over primary goal in pivotal Parkinson’s data

Jul 2, 2024 9:38am

A mouse in its nest peeks out from a tree

Gain's Parkinson's drug helps mice retain cognitive function

Jul 2, 2024 6:00am